ARS Pharmaceuticals 주식 가격. SPRY - 주식 시세, 차트, 과거 거래, 주식 채팅, 재무.

실시간 토론 및 거래 아이디어: 강력한 플랫폼으로 자신있게 거래하세요.

프리미엄

가격

13.50

매수가

13.50

매도가

13.56

거래량

199,715

13.01 일간 변동폭 13.64

4.64 52주 범위 18.49

market_cap

1.312B

전일 종가

13.55

개장가

13.55

최근 거래 시간

13.495

마지막 거래 시간

01:37:52

재정 규모

US$ 2,668,837

VWAP

13.3632

평균 볼륨(3m)

1,066,985

발행 주식

97,185,475

배당수익률

주가수익률

-23.70

주당순이익(EPS)

-0.56

매출

30k

순이익

-54.37M

ARS Pharmaceuticals Inc is a biopharmaceutical company dedicated to empowering at-risk patients and caregivers to better protect themselves from severe allergic reactions that could lead to anaphylaxis. The company is developing neffy, an intranasal epinephrine product in clinical development for pa... ARS Pharmaceuticals Inc is a biopharmaceutical company dedicated to empowering at-risk patients and caregivers to better protect themselves from severe allergic reactions that could lead to anaphylaxis. The company is developing neffy, an intranasal epinephrine product in clinical development for patients and their caregivers with Type I allergic reactions including food, medications, and insect bites that could lead to life-threatening anaphylaxis. 더 보기

섹터

Pharmaceutical Preparations

산업

Pharmaceutical Preparations

웹사이트

ars-pharma.com

본부

Wilmington, Delaware, USA

설립됨

ARS Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the 나스닥 with ticker SPRY. The last closing price for ARS Pharmaceuticals was US$13.55. Over the last year, ARS Pharmaceuticals shares have traded in a share price range of US$ 4.64 to US$ 18.49.

ARS Pharmaceuticals currently has 97,185,475 shares in issue. The market capitalisation of ARS Pharmaceuticals is US$1.32 billion. ARS Pharmaceuticals has a price to earnings ratio (PE ratio) of -23.70.

Form 144 - Report of proposed sale of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

ARS Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Updates

Commercial launch of neffy® (epinephrine nasal spray) underway in the United StatesSupplemental NDA for neffy®1mg dose granted priority review by FDA; PDUFA target date set for March 6...

Form 8-K - Current report

ARS Pharmaceuticals Announces Exclusive Agreement with Global Allergy Leader ALK to Commercialize neffy® in Europe, Canada and Other Geographies Outside the United States

Agreement leverages ALK’s global footprint in developing and commercializing innovative allergy products ARS Pharma to receive an upfront cash payment of $145 million, with total deal...

ARS Pharmaceuticals Announces Conference Call and Webcasts for its Third Quarter 2024 Financial Results and Presentations at Upcoming Conferences

SAN DIEGO, Nov. 06, 2024 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and caregivers to better protect...

ARS Pharmaceuticals Showcases Intranasal Epinephrine Data at 2024 American College of Allergy, Asthma & Immunology (ACAAI) Annual Scientific Meeting

SAN DIEGO, Oct. 24, 2024 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and their caregivers to better protect...

Form 4 - Statement of changes in beneficial ownership of securities

기간	변동	변동 %	시가	고가	저가	평균 일일 거래량	VWAP
1	-1.265	-8.56755841517	14.765	15.25	13.01	1317724	13.88580152	CS
4	-2.62	-16.253101737	16.12	18.49	13.01	1290991	15.20687135	CS
12	-0.2	-1.4598540146	13.7	18.49	11	1066985	14.53099064	CS
26	4.37	47.8641840088	9.13	18.49	7.55	982003	12.82794466	CS
52	8.74	183.613445378	4.76	18.49	4.64	764275	11.12957968	CS
156	8.22	155.681818182	5.28	18.49	2.55	712047	8.48968297	CS
260	8.22	155.681818182	5.28	18.49	2.55	712047	8.48968297	CS

가장 활성
% 상승자
% 패자

기호	가격	볼륨
WORXSCWorx Corporation	US$ 2.0002 (104.10%)	109.68M
CRNCCerence Inc	US$ 4.83 (71.28%)	34.81M
IBGInnovation Beverage Group Limited	US$ 1.135 (43.45%)	8.84M
QUBTQuantum Computing Inc	US$ 5.0514 (37.27%)	90.59M
SPAISafe Pro Group Inc	US$ 4.2701 (33.44%)	38.86M
GLXGGalaxy Payroll Group Ltd	US$ 1.68 (-57.03%)	892.74k
PYXSPyxis Oncology Inc	US$ 2.07 (-45.81%)	9.55M
KURAKura Oncology Inc	US$ 10.08 (-36.64%)	7.96M
BLRXBioLineRx Ltd	US$ 0.3545 (-34.98%)	6.17M
SHOTWSafety Shot Inc	US$ 0.1001 (-33.27%)	2.5k
CDTConduit Pharmaceuticals Inc	US$ 0.111001 (20.26%)	496.04M
NVDANVIDIA Corporation	US$ 145.1021 (-0.54%)	205.78M
AKTSAkoustis Technologies Inc	US$ 0.1003 (15.15%)	184.24M
ELABElevai Labs Inc	US$ 0.0202 (-5.61%)	174.72M
WORXSCWorx Corporation	US$ 2.0002 (104.10%)	108.78M